Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Alaunos Therapeutics, Inc. (TCRT) is a Biotechnology company based in US with a market capitalization of $5.1M. Revenue declined 50.0% year-over-year and free cash flow was negative at -$3M. This page tracks TCRT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 1 employees · IPO Aug 24, 2005
Valuation
Valuation & price
$2.47as of May 17, 2026· -43.3% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$5.1M
Market cap
-50.0%
Revenue growth (YoY)
100.0%
Gross margin
-$3M
Free cash flow (USD)
-$1.4M
Net debt
Net cash position
21.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.59)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 29, 2026Filing
Preclinical Data Announcement
- 8-K eventMay 26, 2026Filing
Preclinical Study Results
- 8-K eventMay 18, 2026Filing
Preclinical Data Announcement
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- Annual reportApr 30, 2026Filing
10-K Filed
- 8-K eventApr 15, 2026Filing
Delisting Notice
- Annual reportMar 31, 2026Filing
10-K Filed
Questions
Frequently asked questions
What is Alaunos Therapeutics, Inc.'s market cap?
Alaunos Therapeutics, Inc. (TCRT) has a market capitalization of $5.1M.
What is TCRT's P/E ratio?
A meaningful P/E ratio is not available for TCRT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is TCRT's price-to-book (P/B) ratio?
TCRT trades at 2.37 times book value per share.
When did Alaunos Therapeutics, Inc. last report earnings?
TCRT last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying TCRT stock?
SEC Form 4 filings show no open-market insider buys at Alaunos Therapeutics, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.